UNC Eshelman School of Pharmacy
Introduction
Pharmacists are drug information experts and are among the most trusted and most accessible health care professionals. Generalists practice in a variety of environments, including community pharmacies, health-system pharmacies, and the pharmaceutical and health care industries. Specialty pharmacy practitioners pursue training beyond the doctor of pharmacy (Pharm.D.) through residencies and fellowships and may ultimately practice in areas such as pediatrics, geriatrics, cardiology, oncology, ambulatory/community care, and others.
Pharmacists evaluate complex approaches to drug therapy and advise patients and other health care professionals on strategies to achieve the best results from pharmaceutical care. Other pharmacists are engaged in practices that monitor, manage, and implement policies affecting drug prescription and use across large groups of patients, such as those enrolled in a health plan.
The UNC Eshelman School of Pharmacy’s doctor of pharmacy is a 4-year professional program that offers a curriculum centered on patient care. Our Pharm.D. program offers a highly immersive curricula, with patient care immersion experiences commencing during students’ second year of study.
Advising
In the UNC Eshelman School of Pharmacy, advising is a form of teaching. Faculty advisors serve as content experts and mentors and are assigned to new students prior to the first semester of study. To fully maximize both curricular and co-curricular experiences, students are encouraged to schedule consistent and ongoing advising appointments throughout the course of their study.
Career Opportunities
Pharmacy offers a variety of opportunities for career advancement and job security in all areas of the health care system, including:
- Community pharmacy, as a practitioner or a manager in a retail pharmacy, clinic, or office practice
- Health system pharmacy, as a practitioner, supervisor, or manager in large or small hospitals, nursing homes, extended care facilities, and health-maintenance organizations
- Pharmaceutical industry, in positions involving research, production, product development, product marketing, and drug information
- Government, in the United States Public Health Service, Veterans Administration, Drug Enforcement Administration, Food and Drug Administration, and military services
Admission Requirements
The doctor of pharmacy requires at least two years of undergraduate study (at least 72 credit hours), followed by four years of study in the professional program.
Applicants must complete all prerequisites by the end of May of the year they plan to enroll.
Students who will have earned a baccalaureate degree prior to enrolling in their first year of the program must complete the math and science prerequisites only.
Students who will not have earned a baccalaureate degree prior to enrolling in their first year of the program must complete both the math and science prerequisites and the general education requirements.
Application Procedures
Students applying to the UNC Eshelman School of Pharmacy must submit complete applications to the Pharm.D. program through the Pharmacy College Application Service (PharmCAS) and the school. For application deadlines, processes, and procedures, visit the website.
Prerequisites
All prerequisite courses must be completed with a letter grade of C minus or better (not Pass/Fail).
If you have a bachelor's degree:
| Code | Title | Hours |
|---|---|---|
| CHEM 101 & 101L | 
General Descriptive Chemistry Iand
Quantitative Chemistry Laboratory I H, F | 4 |
| CHEM 102 & 102L |
General Descriptive Chemistry II and Quantitative Chemistry Laboratory II H, F | 4 |
| CHEM 241 & 241L | Modern Analytical Methods for Separation and Characterization and Laboratory in Separations and Analytical Characterization of Organic and Biological Compounds 1, H | 4 |
| CHEM 261 | Introduction to Organic Chemistry I H | 3 |
| CHEM 262 & 262L | Introduction to Organic Chemistry II and
Laboratory in Organic Chemistry H | 4 |
| BIOL 101 & 101L |
Principles of Biology and
Introductory Biology Laboratory H, F | 4 |
| BIOL 252 & 252L |
Fundamentals of Human Anatomy and Physiology and Fundamentals of Human Anatomy and Physiology Laboratory H | 4 |
| MCRO 251 | Introductory Medical Microbiology | 4 |
| PHYS 114 |
General Physics I: For Students of the Life Sciences F | 4 |
| PHYS 115 |
General Physics II: For Students of the Life Sciences 2, F | 4 |
| MATH 231 |
Calculus of Functions of One Variable I H, F | 4 |
| STOR 151 |
Introduction to Data Analysis | 3 |
| or STOR 155 |
Introduction to Data Models and Inference | |
| CHEM 430 | Introduction to Biological Chemistry H | 3 |
| H | Honors version available. An honors course fulfills the same requirements as the nonhonors version of that course. Enrollment and GPA restrictions may apply. |
| F | FY-Launch class sections may be available. A FY-Launch section fulfills the same requirements as a standard section of that course, but also fulfills the FY-SEMINAR/FY-LAUNCH First-Year Foundations requirement. Students can search for FY-Launch sections in ConnectCarolina using the FY-LAUNCH attribute. |
- 1
Only required for students completing prerequisite courses at UNC–Chapel Hill.
- 2
Not required of students completing CHEM 241/CHEM 241L at UNC–Chapel Hill.
If you do not have a bachelor's degree:
Students enrolling in the program without a bachelor’s degree are required to complete at least two years of undergraduate coursework (at least 60 semester credit hours) including the math, science, and general education prerequisites from a regionally accredited institution.
| Code | Title | Hours |
|---|---|---|
| CHEM 101 & 101L |
General Descriptive Chemistry I and
Quantitative Chemistry Laboratory I H, F | 4 |
| CHEM 102 & 102L |
General Descriptive Chemistry II and Quantitative Chemistry Laboratory II H, F | 4 |
| CHEM 241 & 241L | Modern Analytical Methods for Separation and Characterization and Laboratory in Separations and Analytical Characterization of Organic and Biological Compounds 1, H | 4 |
| CHEM 261 | Introduction to Organic Chemistry I H | 3 |
| CHEM 262 & 262L | Introduction to Organic Chemistry II and
Laboratory in Organic Chemistry H | 4 |
| BIOL 101 & 101L |
Principles of Biology and
Introductory Biology Laboratory H, F | 4 |
| BIOL 252 & 252L |
Fundamentals of Human Anatomy and Physiology and Fundamentals of Human Anatomy and Physiology Laboratory H | 4 |
| MCRO 251 | Introductory Medical Microbiology | 4 |
| PHYS 114 |
General Physics I: For Students of the Life Sciences F | 4 |
| PHYS 115 |
General Physics II: For Students of the Life Sciences 2, F | 4 |
| MATH 231 |
Calculus of Functions of One Variable I H, F | 4 |
| STOR 151 |
Introduction to Data Analysis | 3 |
| or STOR 155 |
Introduction to Data Models and Inference | |
| CHEM 430 | Introduction to Biological Chemistry H | 3 |
| H | Honors version available. An honors course fulfills the same requirements as the nonhonors version of that course. Enrollment and GPA restrictions may apply. |
| F | FY-Launch class sections may be available. A FY-Launch section fulfills the same requirements as a standard section of that course, but also fulfills the FY-SEMINAR/FY-LAUNCH First-Year Foundations requirement. Students can search for FY-Launch sections in ConnectCarolina using the FY-LAUNCH attribute. |
- 1
Only required for students completing prerequisite courses at UNC–Chapel Hill.
- 2
Not required of students completing CHEM 241/CHEM 241L at UNC–Chapel Hill.
General Education Prerequisites
| English 105 (Composition and Rhetoric) | 3 |
| Social sciences; 2 courses; examples of accepted courses include psychology, sociology, economics, political science, and anthropology | 6 |
| Humanities; two courses; examples of accepted courses include English, history, philosophy, ethics, ethnic and gender studies, social justice, or foreign language study | 6 |
Distinguished Professors
Kristy Ainslie, Pharmacoengineering and Molecular Pharmaceutics Jeffrey Aubé, Chemical Biology and Medicinal Chemistry Ronny Bell, Pharmaceutical Outcomes and Policy Bob Blouin, Pharmacotherapy and Experimental Therapeutics Kim Brouwer, Pharmacotherapy and Experimental Therapeutics Stefanie Ferreri, Practice Advancement Stephen Frye, Chemical Biology and Medicinal Chemistry Leaf Huang, Pharmacoengineering and Molecular Pharmaceutics Michael Jay, emeritus, Pharmacoengineering and Molecular Pharmaceutics Alexander Kabanov, Pharmacoengineering and Molecular Pharmaceutics Angela Kashuba, Pharmacotherapy and Experimental Therapeutics, Dean of Eshelman School of Pharmacy
David Lawrence, Chemical Biology and Medicinal Chemistry Craig Lee, Pharmacotherapy and Experimental Therapeutics Jian Liu, Chemical Biology and Medicinal Chemistry Denise Rhoney-Metzger, Practice Advancement Betsy Sleath, Pharmaceutical Outcomes and Policy Alexander Tropsha, Chemical Biology and Medicinal Chemistry
Paul Watkins, Pharmacotherapy and Experimental Therapeutics
Professors of the Practice
John Bamforth, Eshelman Institute for Innovation Jon Easter, Practice Advancement Ouita Gatton, Practice Advancement Anthony Hickey, UNC Catalyst for Rare Disease Stephanie Kiser, Practice Advancement
Professors
Timothy Ives, Practice Advancement Jennifer Elston-Lafata, Pharmaceutical Outcomes and Policy Samuel Lai, Pharmacoengineering and Molecular Pharmaceutics Andrew Lee, Chemical Biology and Medicinal Chemistry
Rihe Liu, Chemical Biology and Medicinal Chemistry
Mary McClurg, Practice Advancement William Zamboni, Pharmacotherapy and Experimental Therapeutics
Associate Professors
Albert Bowers, Chemical Biology and Medicinal Chemistry Yanguang Cao, Pharmacotherapy and Experimental Therapeutics Delesha Carpenter, Pharmaceutical Outcomes and Policy Daniel Crona, Pharmacotherapy and Experimental Therapeutics Julie Dumond, Pharmacotherapy and Experimental Therapeutics Daniel Gonzalez, Pharmacotherapy and Experimental Therapeutics Nathaniel Hathaway, Chemical Biology and Medicinal Chemistry Erin Heinzen Cox, Pharmacotherapy and Experimental Therapeutics Shawn Hingtgen, Pharmacoengineering and Molecular Pharmaceutics Michael Jarstfer, Chemical Biology and Medicinal Chemistry Jacqueline McLaughlin, Practice Advancement Juliane Nguyen, Pharmacoengineering and Molecular Pharmaceutics Sachiko Ozawa, Practice Advancement Gauri Rao, Pharmacotherapy and Experimental Therapeutics Robert Shrewsbury, Practice Advancement Scott Singleton, Chemical Biology and Medicinal Chemistry Kathleen Thomas, Pharmaceutical Outcomes and Policy Carolyn Thorpe, Pharmaceutical Outcomes and Policy Joshua Thorpe, Pharmaceutical Outcomes and Policy Dennis Williams, Pharmacotherapy and Experimental Therapeutics Timothy Wiltshire, Pharmacotherapy and Experimental Therapeutics Qisheng Zhang, Chemical Biology and Medicinal Chemistry
Assistant Professors
Rachel Church, Pharmacotherapy and Experimental Therapeutics Klarissa Jackson, Pharmacotherapy and Experimental Therapeutics Lindsey James, Chemical Biology and Medicinal Chemistry Alan Kinlaw, Pharmaceutical Outcomes and Policy Robert McGinty, Chemical Biology and Medicinal Chemistry Megan Roberts, Pharmaceutical Outcomes and Policy Amanda Seyerle, Pharmaceutical Outcomes and Policy
Teaching Assistant Professor
Laura Rhodes, Practice Advancement
Research Professors
Kenneth Pearce Jr., Center for Integrative Chemical Biology and Drug Discovery (CICBDD)
Xiaodong Wang, Center for Integrative Chemical Biology and Drug Discovery (CICBDD)
Timothy Willson, Structural Genomics Consortium
Research Associate Professors
Eric Bachelder, Pharmacoengineering and Molecular Pharmaceutics
Elena Batrakova, Center for Nanotechnology in Drug Discovery (CNDD)
David Drewry, Structural Genomics Consortium
Juan Li, Pharmacoengineering and Molecular Pharmaceutics
Eugene Muratov, Chemical Biology and Medicinal Chemistry
Samantha Pattenden, Chemical Biology and Medicinal Chemistry
Elias Rosen, Pharmacotherapy and Experimental Therapeutics
Marina Sokolsky-Papkov, Pharmacoengineering and Molecular Pharmaceutics
Yongmei Xu, Chemical Biology and Medicinal Chemistry
Research Assistant Professors
Katelyn Arnold, Chemical Biology and Medicinal Chemistry Alison Axtman, Structural Genomics Consortium Mackenzie Cottrell, Pharmacotherapy and Experimental Therapeutics Anita Crescenzi, Practice Advancement Scott Davis, Pharmaceutical Outcomes and Policy Yury Desyaterik, Pharmacotherapy and Experimental Therapeutics Kevin Frankowski, Chemical Biology and Medicinal Chemistry Masuo Goto, Chemical Biology and Medicinal Chemistry Lauren Haar, Chemical Biology and Medicinal Chemistry Dulcie Lai, Pharmacotherapy and Experimental Therapeutics Jine Li, Chemical Biology and Medicinal Chemistry Melanie Livet, Practice Advancement Jillian Perry, Center for Nanotechnology in Drug Discovery (CNDD) Paul Sapienza, Chemical Biology and Medicinal Chemistry Zhenwei Song, Pharmacotherapy and Experimental Therapeutics Junjiang Sun, Pharmacoengineering and Molecular Pharmaceutics Jacqueline Tiley, Pharmacotherapy and Experimental Therapeutics Qunzhao Wang, Chemical Biology and Medicinal Chemistry Bin Xiao, Pharmacoengineering and Molecular Pharmaceutics
Clinical Professors
Robert Dupuis, Pharmacotherapy and Experimental Therapeutics Adam Persky, Pharmacotherapy and Experimental Therapeutics Jo Ellen Rodgers, Pharmacotherapy and Experimental Therapeutics Mollie Scott, Practice Advancement John Greene Shepherd, Practice Advancement
Clinical Associate Professors
Amanda H. Corbett, Pharmacotherapy and Experimental Therapeutics Wendy Cox, Practice Advancement Stephen Eckel, Practice Advancement Suzanne Harris, Practice Advancement Macary Marciniak, Practice Advancement Nicole Pinelli Reitter, Practice Advancement Philip Rodgers, Practice Advancement Deborah Sturpe, Pharmacotherapy and Experimental Therapeutics Charlene Williams, Practice Advancement
Clinical Assistant Professors
Heidi Anksorus, Practice Advancement Amber Frick, Pharmacotherapy and Experimental Therapeutics Kathryn Fuller, Practice Advancement Kathryn Morbitzer, Practice Advancement Benyam Muluneh, Pharmacotherapy and Experimental Therapeutics Kimberly Sanders, Practice Advancement Amanda Savage, Practice Advancement Carla White, Practice Advancement Jacqueline Zeeman, Practice Advancement
PHCY–Pharmacy
All courses and electives for the Pharm.D. program are listed below by year in the curriculum. See the Student Handbook and the program's Web site for information about course sequence by semester.
Professional Year 1
| Code | Title | Hours |
|---|---|---|
| PHCY 500 | Pharmacy Bridging Course | 3 |
| PHCY 501 | On Becoming a Pharmacist | 1 |
| PHCY 502 | Pathophysiology of Human Disease | 3.5 |
| PHCY 503 | Molecular Foundations of Drug Action | 3.5 |
| PHCY 504 | Evidence-Based Practice | 3 |
| PHCY 508 | Pharmaceutical Calculations | 1 |
| PHCY 509 | Immunizations and Medication Administration Training | 1 |
| PHCY 510 | Foundations of Clinical Pharmacology | 3 |
| PHCY 511 | Foundations of Pharmacokinetics | 3 |
| PHCY 512 | Pharmaceutics and Drug Delivery Systems | 3 |
| PHCY 513L | Pharmaceutical Compounding | 1.5 |
| PHCY 516 | Foundations of Patient Care | 2 |
| PHCY 519 | Self-Care and Nonprescription Medications | 1.5 |
| PHCY 529 | Pharmacotherapy: Foundations | 3 |
| Immersion Experience 1: | 8.0 | |
| Immersion Experience: Community | ||
| Immersion Experience: Health System | ||
| Total Hours | 41 | |
Professional Year 2
| Code | Title | Hours |
|---|---|---|
| PHCY 601L | Patient Care Lab | 1.5 |
| PHCY 609 | The US Healthcare System | 2 |
| PHCY 611 | Applied Clinical Pharmacology | 3 |
| PHCY 617 | The Patient Care Experience | 1.5 |
| PHCY 619 | Business of Healthcare: Focus on the Pharmacy Enterprise | 2 |
| PHCY 630 | Pharmacotherapy: Applied | 4 |
| PHCY 631 | Pharmacotherapy: Integrated I | 5 |
| PHCY 636 | Leadership and Professional Development I | 1 |
| Immersion Experience 2: | 8 | |
| Immersion Experience: Community | ||
| Immersion Experience: Health System | ||
| Immersion Experience: Direct-Patient Care | ||
| Electives | 3.0 | |
| Total Hours | 31 | |
Professional Year 3
| Code | Title | Hours |
|---|---|---|
| PHCY 718 | The Patient Care Experience II | 2 |
| PHCY 722 | Pharmacy Law: Regulation of Pharmacy Practice | 3 |
| PHCY 732 | Integrated Pharmacotherapy II | 5 |
| PHCY 733 | Integrated Pharmacotherapy III | 5 |
| PHCY 737 | Leadership and Professional Development II | 1 |
| Immersion Experience 3: | 8 | |
| Immersion Experience: Community | ||
| Immersion Experience: Health System | ||
| Immersion Experience: Direct-Patient Care | ||
| Electives | 5 | |
| Total Hours | 29 | |
Professional Year 4
| Code | Title | Hours |
|---|---|---|
| PHCY 898 | Professional Development and Career-Readiness: Fourth Year Seminar I | 1 |
| PHCY 899 | Professional Development and Career-Readiness: Fourth Year Seminar II | 1 |
| Immersion Experiences selected from the following options: | 36 | |
| Advanced Immersion Experience: Patient Care Elective I | ||
| Advanced Immersion Experience: Patient Care Elective II | ||
| Advanced Immersion Experience: Non-Patient Care Elective I | ||
| Advanced Immersion Experience: Non-Patient Care Elective II | ||
| Advanced Immersion Experience: Community | ||
| Advanced Immersion Experience: Health Systems | ||
| Advanced Immersion Experience: Ambulatory Care | ||
| Advanced Immersion Experience: General Medicine | ||
| Advanced Immersion Experience: Clinical I | ||
| Advanced Immersion Experience: Clinical II | ||
| Advanced Immersion Experience: Clinical III | ||
| Total Hours | 38 | |
Electives
See the Student Handbook for the Pharm.D. Elective policy. The below list does not include all courses offered by other UNC departments and schools that may be approved electives.
| Code | Title | Hours |
|---|---|---|
| PHCY 608I | Interprofessional Perspectives Diabetes Mellitus Management | 2 |
| PHCY 624 | Research and Scholarship in Pharmacy I | 1.5 |
| PHCY 700 | SHAC: Community Outreach and Service Learning | 0 |
| PHCY 725 | Research and Scholarship in Pharmacy II | 1.5 |
| PHCY 726 | Research and Scholarship in Pharmacy III | 3 |
| PHCY 800 | Geriatric Pharmacy Practice | 3 |
| PHCY 801 | Radiopharmacy I: Introduction to Radiopharmacy | 2 |
| PHCY 802 | Radiopharmacy 2 - The Drugs of Nuclear Medicine | 2 |
| PHCY 803 | Radiopharmacy 3 | 3 |
| PHCY 804 | Travel Medicine Care | 1.5 |
| PHCY 807 | Veterinary Pharmacotherapy | 3 |
| PHCY 808 | Critical Care | 3 |
| PHCY 810 | The Science of Pharmaceutical Compounding | 1 |
| PHCY 811 | Infectious Diseases | 1.5 |
| PHCY 812 | Pediatric Pharmacotherapy | 1.5 |
| PHCY 813 | Clinical Toxicology | 1.5 |
| PHCY 814 | Disaster Preparedness and Emergency Care | 1.5 |
| PHCY 815 | Data Science in Pharmacy | 1 |
| PHCY 817 | Making Medicine: The Process of Drug Development | 1.5 |
| PHCY 822 | Hematology/Oncology Pharmacotherapy | 3 |
| PHCY 823 | International Clinical Classroom Case Discussion | 2 |
| PHCY 824 | Solid Organ Transplantation Pharmacy Practice | 1.5 |
| PHCY 832 | Innovations in Community-Based Pharmacy Practice | 1.5 |
| PHCY 833 | Advanced Cardiovascular Pharmacy | 1.5 |
| PHCY 836 | Prevention, Treatment, and Recovery of Substance Use Disorders | 1.5 |
| PHCY 837 | Pharmacogenetics | 1.5 |
| PHCY 839 | Global and Rural Health: Maximizing Interprofessional Teams to Impact Patient Outcomes | 1 |
| PHCY 840 | Health Policy and Managed Care | 3 |
| PHCY 841 | Rural Pharmacy Health 1: Introduction to Rural Pharmacy Practice | 1.5 |
| PHCY 842 | Rural Pharmacy Health 2: Cultural Responsiveness in Rural Health | 1.5 |
| PHCY 843 | Rural Pharmacy Health 3: Interprofessional Practice | 1.5 |
| PHCY 844 | Rural Pharmacy Health 4: Population Health Management | 1.5 |
| PHCY 846 | Perspectives in Mental Health | 2 |
| PHCY 847 | ||
| PHCY 850 | Pharmacy Internship and Career Development | 1.5 |
| PHCY 851 | Foundations in Ambulatory Care | 2 |
| PHCY 852 | Ambulatory Care Services I | 1.5 |
| PHCY 853 | Ambulatory Care Pharmacy Services II | 1.5 |
| PHCY 854 | Ambulatory Care Capstone Course | 2 |
| PHRS 815 | Foundations in Implementation Science: Examples in Precision Health and Society | 1.5 |
UNC Eshelman School of Pharmacy
301 Pharmacy Lane, CB # 7355, Chapel Hill, NC 27599-7355
(919) 966-9429
